SABCS: Breast Cancer Outcomes Worse for Blacks Despite Similar Gene RS

Share this content:
SABCS: Breast Cancer Outcomes Worse for Blacks Despite Similar Gene RS
SABCS: Breast Cancer Outcomes Worse for Blacks Despite Similar Gene RS

THURSDAY, Dec. 6, 2018 (HealthDay News) -- Black women with breast cancer have worse clinical outcomes even when 21-gene recurrence scores (RS) are similar, according to a study presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 4 to 8 in Texas.

Kathy Albain, M.D., from the Loyola University Chicago Stritch School of Medicine in Maywood, Illinois, and colleagues examined clinicopathologic characteristics, treatment delivered, and clinical outcomes in 9,719 patients from the Trial Assigning Individualized Options for Treatment by race and ethnicity.

The researchers observed no significant difference in the RS distribution or in median or mean RS in blacks versus whites or for Hispanic versus non-Hispanic ethnicity. They also observed no difference in use and type of adjuvant chemotherapy and endocrine therapy or in the duration of endocrine therapy. In the entire population and among patients with an RS of 11 to 25 (intermediate risk for recurrence), black race was associated with worse clinical outcomes (invasive disease-free survival, hazard ratios, 1.33 [P = 0.005] and 1.49 [P = 0.001], respectively; distant relapse-free interval, hazard ratios, 1.21 [P = 0.28] and 1.60 [P = 0.02], respectively; relapse-free interval, hazard ratios, 1.39 [P = 0.02] and 1.80 [P < 0.001], respectively; and overall survival, hazard ratios, 1.52 [P = 0.005] and 1.67 [P = 0.003], respectively). Compared with non-Hispanic ethnicity, Hispanic ethnicity was generally associated with better outcomes.

"Our results suggest that biological differences may contribute to the significantly different outcomes of black women compared to others with breast cancer," Albain said in a statement.

One author disclosed financial ties to the pharmaceutical industry; the genomic test used in the trial was the Oncotype DX Breast Recurrence Score test from Genomic Health.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »